Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia.


Journal

Advances in respiratory medicine
ISSN: 2543-6031
Titre abrégé: Adv Respir Med
Pays: Switzerland
ID NLM: 101697329

Informations de publication

Date de publication:
31 May 2023
Historique:
received: 11 02 2023
revised: 27 04 2023
accepted: 24 05 2023
medline: 29 6 2023
pubmed: 27 6 2023
entrez: 27 6 2023
Statut: epublish

Résumé

A substantial increase in broad-spectrum antibiotics as empirical therapy in patients with community-acquired pneumonia (CAP) has occurred over the last 15 years. One of the driving factors leading to that has been some evidence showing an increased incidence of drug-resistant pathogens (DRP) in patients from a community with pneumonia, including methicillin-resistant

Identifiants

pubmed: 37366804
pii: arm91030018
doi: 10.3390/arm91030018
pmc: PMC10295768
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

224-238

Références

PLoS One. 2015 Apr 10;10(4):e0119528
pubmed: 25860142
JAMA Intern Med. 2020 Apr 1;180(4):552-560
pubmed: 32065604
PLoS One. 2019 Jun 5;14(6):e0217908
pubmed: 31166993
J Gen Intern Med. 2018 Jul;33(7):1060-1068
pubmed: 29679226
Semin Respir Crit Care Med. 2020 Aug;41(4):480-495
pubmed: 32629487
Clin Infect Dis. 2016 Sep 1;63(5):e61-e111
pubmed: 27418577
Clin Infect Dis. 2011 Jul 15;53(2):107-13
pubmed: 21690616
J Antimicrob Chemother. 2016 Feb;71(2):290-5
pubmed: 26568581
Ann Intern Med. 2019 Aug 6;171(3):153-163
pubmed: 31284301
Microbiologyopen. 2022 Feb;11(1):e1260
pubmed: 35212478
Intern Emerg Med. 2012 Dec;7(6):523-31
pubmed: 22688529
Lancet. 2023 Dec 17;400(10369):2221-2248
pubmed: 36423648
Pharmacotherapy. 2014 Jul;34(7):670-6
pubmed: 24855041
Expert Opin Drug Saf. 2018 May;17(5):499-508
pubmed: 29633867
Chest. 2016 Aug;150(2):415-25
pubmed: 27060725
Clin Infect Dis. 2014 Feb;58(3):330-9
pubmed: 24270053
Front Microbiol. 2018 Oct 08;9:2419
pubmed: 30349525
JAMA. 2016 Feb 9;315(6):593-602
pubmed: 26864413
BMC Infect Dis. 2014 May 10;14:252
pubmed: 24885158
Chest. 2010 Jun;137(6):1283-8
pubmed: 20154075
Crit Care Med. 2018 Jan;46(1):12-20
pubmed: 29088001
BMC Pulm Med. 2022 Oct 14;22(1):379
pubmed: 36242006
Arch Intern Med. 2008 Nov 10;168(20):2205-10
pubmed: 19001196
Am J Respir Crit Care Med. 2005 Feb 15;171(4):388-416
pubmed: 15699079
Eur Respir J. 2019 Jul 4;54(1):
pubmed: 31023851
Clin Infect Dis. 2010 Jan 15;50(2):202-9
pubmed: 20014950
Lancet Infect Dis. 2016 Dec;16(12):1364-1376
pubmed: 27593581
Eur Respir J. 2010 Mar;35(3):598-605
pubmed: 19679601
Am J Respir Crit Care Med. 1998 Feb;157(2):531-9
pubmed: 9476869
Antimicrob Agents Chemother. 2014;58(2):859-64
pubmed: 24277023
Open Forum Infect Dis. 2017 Jun 20;4(2):ofx088
pubmed: 28730159
Clin Infect Dis. 2018 Mar 19;66(7):1004-1012
pubmed: 29136126
BMC Infect Dis. 2013 Jun 06;13:268
pubmed: 23742753
Respir Med. 2013 Aug;107(8):1266-70
pubmed: 23756035
Clin Infect Dis. 2021 Oct 5;73(7):e1579-e1586
pubmed: 33382398
Int J Mol Sci. 2022 Nov 01;23(21):
pubmed: 36362106
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Redox Rep. 2002;7(5):317-9
pubmed: 12688519
Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67
pubmed: 31573350
Clin Infect Dis. 2018 Nov 28;67(12):1815-1823
pubmed: 29718143
Chest. 2005 Dec;128(6):3854-62
pubmed: 16354854
Pharmacotherapy. 2014 Jul;34(7):662-9
pubmed: 24753221
J Antimicrob Chemother. 2015 May;70(5):1573-9
pubmed: 25558075
Am J Med Sci. 2014 May;347(5):347-56
pubmed: 24029796
Antimicrob Resist Infect Control. 2022 Jul 14;11(1):95
pubmed: 35836272
JAMA Intern Med. 2020 Apr 1;180(4):485-486
pubmed: 32065598
World J Microbiol Biotechnol. 2021 May 28;37(6):108
pubmed: 34046779
Am J Respir Crit Care Med. 2013 Oct 15;188(8):985-95
pubmed: 23855620
J Antimicrob Chemother. 2010 Apr;65(4):608-18
pubmed: 20179023
Molecules. 2021 May 02;26(9):
pubmed: 34063264
Clin Infect Dis. 2010 Apr 15;50(8):1081-3
pubmed: 20214473
Int J Infect Dis. 2022 Nov;124:124-132
pubmed: 36116670
Eur J Clin Pharmacol. 2012 Sep;68(9):1243-55
pubmed: 22411630
Clin Infect Dis. 2012 Feb 15;54(4):470-8
pubmed: 22109954
Respirology. 2016 Jan;21(1):157-63
pubmed: 26682638
BMC Infect Dis. 2015 Jul 01;15:254
pubmed: 26126606
Respirology. 2013 Feb;18(2):364-8
pubmed: 23066809
BMC Infect Dis. 2013 Aug 09;13:370
pubmed: 23937553
BMJ. 2010 May 18;340:c2096
pubmed: 20483949
Ann Am Thorac Soc. 2015 Feb;12(2):153-60
pubmed: 25521229
Int J Tuberc Lung Dis. 2013 May;17(5):704-9
pubmed: 23575340
J Am Geriatr Soc. 2009 Jun;57(6):1030-5
pubmed: 19460091
Respirology. 2014 May;19(4):549-55
pubmed: 24661357
Infect Control Hosp Epidemiol. 2022 Sep 29;:1-8
pubmed: 36172877
Infect Control Hosp Epidemiol. 2021 Jan;42(1):84-88
pubmed: 32703320
Antibiotics (Basel). 2021 Jan 19;10(1):
pubmed: 33477994
Arch Intern Med. 2002 Sep 9;162(16):1849-58
pubmed: 12196083
Clin Infect Dis. 2012 Mar 1;54(5):621-9
pubmed: 22247123
Am J Med. 2010 Apr;123(4 Suppl):S26-38
pubmed: 20350633
Lancet. 2021 Sep 4;398(10303):906-919
pubmed: 34481570
Eur Respir J. 2018 Aug 9;52(2):
pubmed: 29976651
Thorax. 2013 Nov;68(11):997-9
pubmed: 23774884
Clin Infect Dis. 2019 Apr 24;68(9):1482-1493
pubmed: 31222287
Crit Care Med. 2017 Apr;45(4):600-606
pubmed: 28291091
Clin Infect Dis. 2015 Nov 1;61(9):1403-10
pubmed: 26223995
Clin Infect Dis. 2018 Jun 18;67(1):1-7
pubmed: 29340593
Antimicrob Agents Chemother. 2016 Apr 22;60(5):2652-63
pubmed: 26856838
Respir Med. 2012 Nov;106(11):1606-12
pubmed: 22917808
Front Public Health. 2019 Aug 13;7:221
pubmed: 31475127
Eur Respir J. 2011 Oct;38(4):878-87
pubmed: 21436359

Auteurs

Francesco Amati (F)

Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milan, Italy.
Respiratory Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy.

Francesco Bindo (F)

Respiratory Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy.
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, 20122 Milan, Italy.

Anna Stainer (A)

Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milan, Italy.
Respiratory Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy.

Andrea Gramegna (A)

Department of Pathophysiology and Transplantation, Università degli Studi di Milano, 20122 Milan, Italy.
Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Marco Mantero (M)

Department of Pathophysiology and Transplantation, Università degli Studi di Milano, 20122 Milan, Italy.
Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Mattia Nigro (M)

Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milan, Italy.
Respiratory Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy.

Linda Bussini (L)

Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milan, Italy.
Infectious Diseases Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, 20089 Milan, Italy.

Michele Bartoletti (M)

Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milan, Italy.
Infectious Diseases Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, 20089 Milan, Italy.

Francesco Blasi (F)

Department of Pathophysiology and Transplantation, Università degli Studi di Milano, 20122 Milan, Italy.
Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Stefano Aliberti (S)

Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milan, Italy.
Respiratory Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH